Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume 94, Issue 3 , Pages 265-270 , May 2000

A severe epidemic of meningococcal meningitis in Nigeria, 1996

  • Idris Mohammed

      Affiliations

    • Corresponding Author InformationAuthor for correspondence.
    • Department of Medicine, Maiduguri, Nigeria
    • ,
  • Abdussalam Nasidi

      Affiliations

    • Department of Disease Control and International Health, Federal Ministry of Health, Abuja, Nigeria
    • ,
  • A.S. Alkali

      Affiliations

    • Department of Medicine, Maiduguri, Nigeria
    • ,
  • M.A. Garbati

      Affiliations

    • Department of Medicine, Maiduguri, Nigeria
    • ,
  • E.K. Ajayi-Obe

      Affiliations

    • Department of Medicine, Maiduguri, Nigeria
    • ,
  • Kudi A. Audu

      Affiliations

    • Department of Microbiology, University of Maiduguri, P.M.B. 1069, Bama Road, Maiduguri, Nigeria
    • ,
  • Abdulmumini Usman

      Affiliations

    • Epidemiological Unit, Kano State Ministry of Health, Kano, Nigeria
    • ,
  • Suleiman Abdullahi

      Affiliations

    • Infectious Diseases Hospital, Sabon Gari, Kano, Nigeria

Received 9 August 1999 ,Revised 27 October 1999 ,Accepted 17 November 1999.

References 

  1. Artenstein MS, Gold R, Zimmerly JG, Wyle FA, Schneider H, Harkins C. Prevention of meningococcal disease by group C polysaccharide vaccine. New England Journal of Medicine. 1970;282:417–420
  2. Belcher DW, Sherriff AC, Nimo KP, Chew GL, Richardson WD, Voros A, et al. Meningococcal meningitis in northern Ghana: epidemiology and control measures. American Journal of Tropical Medicine and Hygiene. 1977;26:748–755
  3. Binkin N, Band J. Epidemic meningococcal meningitis in Bamako, Mali: pidemiological features and analysis of vaccine efficacy. Lancet. 1982;ii:315–318
  4. Blakebrough IS, Gilles HM. The effect of rifampicin on meningococcal carriage in families in northern Nigeria. Journal of Infection. 1980;2:137–143
  5. Bwala SA, Mohammed I, Onwuchekwa AC, Gashau AA. An outbreak of meningococcal meningitis in Maiduguri, Borno State, Nigeria. 1. Clinical aspects. Nigerian Medical Practitioner. 1989;18:31–33
  6. Chalmers AJ, O'Farrell WR. Preliminary remarks upon epidemic cerebrospinal meningitis as seen in the Anglo-Egyptian Sudan. Journal of Tropical Medicine and Hygiene. 1916;29:101–116 Chalmers AJ, O'Farrell WR. Preliminary remarks upon epidemic cerebrospinal meningitis as seen in the Anglo-Egyptian Sudan. Journal of Tropical Medicine and Hygiene. 1916;29:117–129
  7. Cochi SL, Markowitz LE, Joshi DD, Owens RC, Stenhouse DH, Regmi DN, et al  Control of group A meningococcal meningitis in Nepal. International Journal of Epidemiology. 1987;16:91–97
  8. Davis LJ. A bacteriological investigation of epidemic cerebrospinal meningitis in the southern Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1931;24:617–622
  9. Ettori D, Sliou P, Renaudet J, Stoeckel Ph. Le vaccin antiméningococcique polysaccharidique du type A: premiers essais controles en Afrique de l'ouest. Médecine Tropicale. 1977;37:230
  10. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. 1. The role of humoral antibodies. Journal of Experimental Medicine. 1969;129:1307–1326
  11. Greenwood BM. Meningococcal meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1999;93:341–353
  12. Greenwood BM, Wali SS. Control of meningo-coccal infection in the African meningitis belt by selective vaccination. Lancet. 1980;i:729–732
  13. Greenwood BM, Bradley AK, Cleland PG, Haggie MHK, Hassan-King M, Lewis LS, et al. An epidemic of meningococcal infection at Zaria, northern Nigeria. 1. General epidemiological features. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1979;73:557–562
  14. Greenwood BM, Whittle HC, Bradley AK, Fayet MT, Gilles HM. The duration of the antibody response to meningococcal vaccination in an African village. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1980;74:756–760
  15. Greenwood BM, Bradley AK, Smith AW, Wall RA. Mortality from meningococcal disease during an epidemic in The Gambia, West Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1987;81:536–538
  16. Haelterman E, Boelaert M, Suetens C, Blok L, Henkens M, Toole MJ. Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp. Tropical Medicine and International Health. 1996;1:385–392
  17. Mohammed I, Damisah MM. The immunological response to polyvalent meningococcal vaccine in Bauchi State, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1982;76:351–353
  18. Mohammed I, Zaruba K. Control of epidemic meningococcal meningitis by mass vaccination. Lancet. 1981;ii:80–83
  19. Mohammed I, Obineche EN, Onyemelukwe GC, Zaruba K. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria. Journal of Infection. 1984;9:190–196
  20. Mohammed I, Onyemelukwe GC, Obineche EN, Gupta N, Oyeyinka GO. Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination. Journal of Infection. 1984;9:197–202
  21. Monto AS, Brandt BL, Artenstein MS. Response of children to Neisseria meningitidis polysaccharide vaccines. Journal of Infectious Diseases. 1973;127:394–400
  22. Moore PS, Reeves MW, Schwartz B, Gellin BG, Broome CV. Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet. 1989;ii:260–263
  23. Moore PS, Plikaytis BD, Bolan GA, Oxtoby MJ, Yada A, Zougba A, et al. Detection of meningitis epidemics in Africa: a population based analysis. International Journal of Epidemiology. 1992;21:155–162
  24. Pecoul B, Varaine F, Keita M, Soga G, Djibo A, Soula G, et al. Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis. Lancet. 1991;338:862–866
  25. Peltola H, Makela PH, Kayhty H, Jousimies H. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. New England Journal of Medicine. 1977;279:689–691
  26. Rey M, Ouedraogo L, Diop-Mar I, Danjou G, Buettre J, Sow A, et al. Traitement de la méningite cérébrospinale épidemique par injection intramusculaire unique de chloramphenicol en suspension huileuse. Afrique Médicale. 1975;14:615–618
  27. Riding D, Corkhill NL. Prophylactic vaccination in epidemic meningitis. Journal of Hygiene. 1932;32:258–267
  28. Ritmeijer K. Médecins sans Frontières and the meningitis epidemic in Niger in 1995: vaccinate or treat?. Nederlands Tijdschrift voor Geneeskunde. 1996;140:1613–1616
  29. Varaine F, Caugant DA, Riou JY, Kondé MK, Soga G, Nshimirimana D, et al. Meningitis outbreaks and vaccination strategy. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1997;91:3–7
  30. Vollum RL, Griffiths WW. An experiment in the prevention of meningococcal meningitis in Nigeria. Journal of Clinical Pathology. 1962;15:50–53
  31. Wahdan MH, Rizk F, El-Akkad AM, El Ghoroury AA, Hablas R, Girgis NI, et al. A controlled field trial of a serogroup A meningococcal polysaccharide vaccine. Bulletin of the World Health Organization. 1973;48:667–673
  32. Wali SS, Macfarlane JT, Weir WRC, Cleland PG, Ball PAJ, Hassan-King M, et al. Single injection treatment of meningococcal meningitis. 2. Long acting chloramphenicol. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1979;73:698–702
  33. WHO . Control of Epidemic Meningococcal Disease. In: WHO Practical Guidelines. Lyon: Foundation Marcel Mérieux; 1995;
  34. Williams EGH, Williams MH. Cerebrospinal meningitis. Journal of Tropical Medicine. 1900;3:83–85
  35. Williams EGH, Williams MH. Cerebrospinal meningitis. Journal of Tropical Medicine. 1901;4:22–23

PII: S0035-9203(00)90316-X

Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume 94, Issue 3 , Pages 265-270 , May 2000

Article Tools